Low-molecular-weight heparins and heparinoids

Barry NJ Walters and Dorothy Graham
Med J Aust 2003; 178 (8): . || doi: 10.5694/j.1326-5377.2003.tb05268.x
Published online: 21 April 2003

To the Editor: In a valuable review of low-molecular-weight heparins (LMWH), Eikelboom and Hankey1 stray off the beaten path into the unwelcoming area of obstetric therapeutics — a notoriously hostile environment replete with traps and hazards. Their statement that "low-molecular-weight heparins are being used increasingly in pregnant women with prosthetic heart valves and for the prevention and treatment of venous thromboembolism" is contentious and requires considerable qualification.


  • 1. Eikelboom JW, Hankey GJ. Low molecular weight heparins and heparinoids. Med J Aust 2002; 177: 379-383. <eMJA full text>
  • 2. Anticoagulation in pregnancy and the puerperium. Med J Aust 2001; 175: 258-263. <eMJA full text>
  • 3. Ginsberg J, Greer I, Hirsh J. Use of antithrombotic agents during prenancy. Chest 2001; 119: 122S-131S.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.